Eupraxia Pharmaceuticals Inc at HC Wainwright Investment Conference - New York Transcript

Sep 11, 2023 - Sep 13, 2023 / NTS GMT
Douglas MacPherson - H.C. Wainwright & Co., LLC - Analyst

Hello, and good afternoon. Thank you for joining us for the H.C. Wainwright 25th Annual Global Investment Conference on September 11 through 13, 2023. I'm Douglas MacPherson, and I'm an equity research associate at H.C. Wainwright. We are confident that we are going to be able to provide you with value, with over 650 companies presenting at this conference, in multiple sectors devoted to life sciences, cryptocurrency, blockchain, fintech, cleantech, metals and mining, and more.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to both public and private companies across multiple sectors and regions. We have a total of 25 publishing senior analysts and over 620 companies covered across all sectors. Please visit hcwco.com for more information.

Now with that said, we have a very productive, enjoyable, and informative session ahead of us. And I'd like to introduce you to our presenter for this session. Please welcome James Helliwell, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot